MARKET

CTKB

CTKB

Cytek Biosciences, Inc.
NASDAQ
5.52
-0.24
-4.17%
After Hours: 5.71 +0.19 +3.41% 18:56 11/12 EST
OPEN
5.68
PREV CLOSE
5.76
HIGH
5.69
LOW
5.45
VOLUME
789.06K
TURNOVER
--
52 WEEK HIGH
6.34
52 WEEK LOW
3.310
MARKET CAP
721.93M
P/E (TTM)
-8.7452
1D
5D
1M
3M
1Y
5Y
1D
What Cytek Biosciences Holders Got Right
Simply Wall St · 1d ago
Cytek Biosciences price target raised to $7 from $6 at Stephens
TipRanks · 2d ago
Cytek Biosciences Is Maintained at Overweight by Stephens & Co.
Dow Jones · 2d ago
Cytek Biosciences Price Target Raised to $7.00/Share From $6.00 by Stephens & Co.
Dow Jones · 2d ago
Stephens & Co. Maintains Overweight on Cytek Biosciences, Raises Price Target to $7
Benzinga · 2d ago
Weekly Report: what happened at CTKB last week (1102-1106)?
Weekly Report · 3d ago
Cytek Biosciences, Inc. (NASDAQ:CTKB) Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St · 5d ago
Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript
The Motley Fool · 11/05 18:29
More
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Webull offers Cytek Biosciences Inc stock information, including NASDAQ: CTKB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTKB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTKB stock methods without spending real money on the virtual paper trading platform.